drugset / Trial / NCT02314403
Renal Allograft Tolerance Through Mixed Chimerism (Belatacept)
NaSingle-groupOpen-labelTreatment
Summary
This study will examine the safety and effectiveness of a combination kidney and bone marrow transplant from a haplo-identical related donor. An investigational medication and other treatments will be given prior to and after the transplant to help protect the transplanted kidney from being attacked by the body's immune system
Timeline
- Start
- 2015-02
- Primary completion
- 2021-03
- Completion
- 2021-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | ATG | Unknown | — | — |
| Background | Belatacept | Protein / enzyme biologic | 10 mg/kg | — |
| Background | Rituximab | Monoclonal antibody | — | — |